Home/Sana Biotechnology/Richard Mulligan
RM

Richard Mulligan

Vice Chairman of the Board

Sana Biotechnology

Sana Biotechnology Pipeline

DrugIndicationPhase
UP421Type 1 diabetesPre-Clinical
SC451Type 1 diabetesPre-Clinical
SG293B-cell Malignancies (Oncology) & B-cell Related Autoimmune DiseasesPre-Clinical